Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen

Details for Australian Patent Application No. 2005227072 (hide)

Owner Laboratoires Besins International

Inventors Le Nestour, Elisabeth

Agent Freehills

Pub. Number AU-B-2005227072

PCT Pub. Number WO2005/092309

Priority 04290761.8 22.03.04 EP; 10/805,528 22.03.04 US

Filing date 10 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 19 August 2010

International Classifications

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092309 Priority application(s): WO2005/092309

19 August 2010 Application Accepted

  Published as AU-B-2005227072

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227073-Chemically stable compositions of 4-hydroxy tamoxifen

2005227064-Methods of protein fractionation using high performance tangential flow filtration